Original language | English |
---|---|
Number of pages | 1 |
Journal | Annals of Oncology |
Volume | 28 |
Publication status | Published - Sept 2017 |
Externally published | Yes |
Event | 42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain Duration: 8 Sept 2017 → 12 Sept 2017 |
Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)
T. Meniawy, G. Richardson, A. Townsend, J. Desai, Hui K. Gan, Michael Friedlander, L. Horvath, M. B. Jameson, S. Sandhu, Z. Wu, Z. Qin, K. Kang, B. Markman
Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review